Skip to main content
Aller à la page d’accueil de la Commission européenne (s’ouvre dans une nouvelle fenêtre)
français fr
CORDIS - Résultats de la recherche de l’UE
CORDIS
Contenu archivé le 2024-06-16

Cell death: from basic principles to therapeutic application

Objectif

Deregulation of cell death causes many human diseases, e.g. cancer, which represent major social and health challenges. This RTN links up 13 academic and 2 industrial partners of recognised international stature in a well-defined collaborative research project to provide a platform for structured training, transfer of knowledge (ToK) and career development in cell death research. The joint project aims at deciphering molecular mechanisms of cell death to develop better cancer therapies (new prognostic biomarkers, new cancer drugs), relevant to the objective of combating cancer (priority 1, 6th framework program). Translation of new knowledge from bench-to-bedside is fostered by interdisciplinary and intersectorial ToK. Innovation and commercial exploitation is facilitated by academia-industry cooperation including an SME. The network's training program addresses important and timely training/ToK needs and fully exploits the network's interdisciplinary, intersectorial and transeuropean potential, combining loc al specialist with network-wide training adapted to the targeted researchers. Visits/secondments including an industrial placement, education in complementary skills and mentoring should advise trainees on new opportunities for multiple career paths, taking into account the broader needs of the European labour market for researchers. All this contributes to create a new European cadre of researchers with interdisciplinary/intersectorial skills, technical excellence, flexibility and humanity. The network realises European added value by integrating different disciplines, industry-academia cooperation, overcoming fragmentation, structuring the European Research Area through integration of New Member and Associated Countries and less-favoured regions, promoting women in science and by enhancing Europe's attractiveness for researchers and competitivity. Thus, this RTN is expected to yield major breakthroughs in combating cancer with huge socio-economic impact.

Champ scientifique (EuroSciVoc)

Ce projet n'a pas encore été classé par EuroSciVoc.
Proposez les domaines scientifiques qui vous semblent les plus pertinents et aidez-nous à améliorer notre service de classification.

Mots‑clés

Thème(s)

Appel à propositions

FP6-2005-MOBILITY-1
Voir d’autres projets de cet appel

Régime de financement

RTN - Marie Curie actions-Research Training Networks

Coordinateur

KLINIKUM DER JOHANN WOLFGANG GOETHE-UNIVERSITAET
Contribution de l’UE
Aucune donnée
Coût total
Aucune donnée

Participants (17)